statistics.jpg
pregnant woman.jpg
world-centralasia.jpg

Prenatal testing for every expecting mother


SCROLL DOWN

Prenatal testing for every expecting mother


More than 3,000,000 babies are born with serious genetic defects every year.

statistics.jpg

BillionToOne has developed the most accurate and multiplexable DNA molecular counting technology.


BillionToOne has developed the most accurate and multiplexable DNA molecular counting technology.


Our novel technology can detect disorders such as sickle cell disease and cystic fibrosis through a simple blood test.

 

 

 

 

 

 

As the fetus develops, a small number of fetal cells dies, and their DNA molecules enter into the maternal bloodstream. BillionToOne has developed an accurate molecular counter that takes advantage of the freely circulating fetal DNA to determine whether the fetus has genetic disorders. Our molecular counting platform decreases sequencing costs and making it possible to detect even single-gene disorders. Thus, only our novel technology can accurately detect disorders such as cystic fibrosis, sickle-cell disease, spinal muscular atrophy, and thalassemias through a simple blood test.

pregnant woman.jpg

Our mission is to make prenatal diagnostics safe and affordable for all.


Our mission is to make prenatal diagnostics safe and affordable for all.


Amniocentesis is an invasive and risky procedure. In contrast, we detect these disorders via a safe and simple blood test of the mother.

 

 

 

Amniocentesis is the standard across the world for prenatal diagnostics, yet it is an extremely invasive procedure, in which a long needle is inserted into the womb to extract fetal cells from the amniotic fluid. It carries a ~0.5% miscarriage risk. Because of the risk involved, it is only done in cases in which there is already a suspicion of genetic disorder in the baby. Instead, BillionToOne has developed a non-invasive alternative that is both useful for everyone and affordable for the majority of the world.

world-centralasia.jpg

Join us in our journey to transform molecular diagnostics.


Join us in our journey to transform molecular diagnostics.